Healthcare provider profile · identity verified

Kristen Dyan Colbert

Nurse Practitioner · OKMULGEE, OK · NPI 1891108593

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	266	36
Rosuvastatin Calcium	Rosuvastatin Calcium	246	36
Amlodipine Besylate	Amlodipine Besylate	235	31
Omeprazole	Omeprazole	225	32
Losartan Potassium	Losartan Potassium	211	26
Lisinopril	Lisinopril	198	24
Synthroid	Levothyroxine Sodium	184	24
Potassium Chloride	Potassium Chloride	176	24
Fluticasone Propionate	Fluticasone Propionate	156	26
Metoprolol Succinate	Metoprolol Succinate	140	16
Furosemide	Furosemide	118	15
Jardiance	Empagliflozin	113	16
Pantoprazole Sodium	Pantoprazole Sodium	99	11
Fluoxetine Hcl	Fluoxetine Hcl	97	11
Montelukast Sodium	Montelukast Sodium	95	14
Sertraline Hcl	Sertraline Hcl	95	13
Gabapentin	Gabapentin	93	13
Hydrochlorothiazide	Hydrochlorothiazide	92	12
Spiriva Respimat	Tiotropium Bromide	87	suppressed
Metformin Hcl	Metformin Hcl	82	12
Novolog Flexpen	Insulin Aspart	79	suppressed
Baclofen	Baclofen	75	11
Atenolol	Atenolol	73	suppressed
Eliquis	Apixaban	70	11
Ozempic	Semaglutide	69	13
Celecoxib	Celecoxib	66	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	66	suppressed
Buspirone Hcl	Buspirone Hcl	65	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	64	17
Duloxetine Hcl	Duloxetine Hcl	63	suppressed
Diclofenac Sodium	Diclofenac Sodium	60	14
Droplet Pen Needle	Pen Needle, Diabetic	56	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	52	suppressed
Bupropion Xl	Bupropion Hcl	48	suppressed
Allopurinol	Allopurinol	46	suppressed
Clopidogrel	Clopidogrel Bisulfate	43	suppressed
Ezetimibe	Ezetimibe	43	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	42	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	42	suppressed
Trazodone Hcl	Trazodone Hcl	42	suppressed
Carvedilol	Carvedilol	38	suppressed
Alogliptin	Alogliptin Benzoate	37	suppressed
Naproxen	Naproxen	35	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Finasteride	Finasteride	32	suppressed
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Famotidine	Famotidine	26	suppressed
Meloxicam	Meloxicam	25	suppressed
Tresiba Flextouch U-200	Insulin Degludec	24	suppressed
Valacyclovir	Valacyclovir Hcl	23	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Humalog Kwikpen U-100	Insulin Lispro	20	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Simvastatin	Simvastatin	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Tramadol Hcl	Tramadol Hcl	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Topiramate	Topiramate	12	suppressed
Clonidine	Clonidine	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Linzess	Linaclotide	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error